2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee

J Am Coll Cardiol. 2020 Sep 1;76(9):1117-1145. doi: 10.1016/j.jacc.2020.05.037. Epub 2020 Aug 5.
No abstract available

Keywords: ACC Expert Consensus Decision Pathway; GLP-1RA; SGLT2 inhibitor; atherosclerotic cardiovascular disease; cardiovascular risk reduction; diabetes; type 2 diabetes.

Publication types

  • Practice Guideline
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cardiology / methods
  • Cardiology / standards*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / therapy*
  • Clinical Decision-Making / methods
  • Committee Membership
  • Consensus*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / therapy*
  • Expert Testimony / standards*
  • Heart Disease Risk Factors
  • Humans
  • Research Report / standards*
  • Risk Reduction Behavior
  • United States / epidemiology